SummitTX Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.96M Buy
96,070
+10,000
+12% +$204K 0.08% 250
2025
Q1
$1.56M Buy
+86,070
New +$1.56M 0.07% 297